Click on the links below to view the latest news stories from leading media outlets highlighting ODPRN research and scientists.
In Ontario, the report says, 695 people died of confirmed or suspected opioid-related causes in the first three-and-a-half months of the pandemic, an increase of 38 per cent compared to the same period of time before the pandemic began.
While we are aware of shifting drug utilization patterns, the extent and effect on patients and health system costs in Canada remains unexplored. We have no idea how many people are affected by drug shortages in Canada.
“Academic detailing in nursing homes may not be an effective intervention to reduce antipsychotic prescribing in an environment where standard quality improvement supports are working,” Mina Tadrous, PharmD, MS, PhD, of [ICES] in Toronto, told Healio Psychiatry. “This study took place at a time when nursing homes were already receiving extensive audit and feedback and there was large media/public attention on the issue.”
“We don’t have any deep understanding of the drug supply across this country … It’s a national issue that we should be all teaming up and trying to do together.”
Mina Tadrous is a pharmacist and researcher in Toronto who monitors pharmaceutical supplies. He said pharmacists are concerned about drugs such as life-saving inhalers that people might stockpile based on misinformation circulating about potential treatments for COVID-19.
The Royal College of Dental Surgeons of Ontario introduced a new dental opioid prescribing guideline in November 2015. The [ODPRN] examined whether introduction of this guideline was associated with changes in opioid prescribing patterns.